X

Vous n'êtes pas connecté

Maroc Maroc - WASHINGTONTIMES.COM - Auto - 30/Jul 15:17

FDA vaccine chief leaving agency after less than 3 months

The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and conservative allies of President Donald Trump.

Articles similaires

Sorry! Image not available at this time

Kennedy Says FDA Reviewing Safety of Abortion Pill Mifepristone

drugs.com - 14:09

MONDAY, Sept. 29, 2025 — The U.S. Food and Drug Administration (FDA) is reviewing the safety of mifepristone, a drug used in medication...

Sorry! Image not available at this time

Krystal Biotech Announces FDA Approval of Updated Vyjuvek Label

drugs.com - 15/Sep 20:09

PITTSBURGH, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States...

Sorry! Image not available at this time

FDA Expands Cinnamon Recall After Elevated Levels of Lead Detected in Product

wn.com - 19/Sep 21:28

The Food and Drug Administration (FDA) announced that it has added another cinnamon product to its public...

Sorry! Image not available at this time

FDA Expands Cinnamon Recall After Elevated Levels of Lead Detected in Product

wn.com - 19/Sep 21:28

The Food and Drug Administration (FDA) announced that it has added another cinnamon product to its public...

Sorry! Image not available at this time

Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language (Elanco Animal Health Inc)

wn.com - 23/Sep 11:51

) FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines...

Sorry! Image not available at this time

Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language (Elanco Animal Health Inc)

wn.com - 23/Sep 11:51

) FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines...

Sorry! Image not available at this time

REPL Stock Plunges 54% in 3 Months After FDA Rejects Skin Cancer Drug

zacks.com - 24/Sep 15:06

Replimune stock dives 54% over three months after the FDA rejects its RP1/Opdivo melanoma drug filing, delaying its first potential product launch.

Sorry! Image not available at this time

FDA to Approve New Use of Cancer Drug, Leucovorin for Autism Symptoms in Kids

drugs.com - 23/Sep 14:09

TUESDAY, Sept. 23, 2025 — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate...

Sorry! Image not available at this time

FDA to Approve New Use of Cancer Drug, Leucovorin for Autism Symptoms in Kids

drugs.com - 23/Sep 14:09

TUESDAY, Sept. 23, 2025 — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate...

Sorry! Image not available at this time

FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)

drugs.com - 25/Sep 17:09

Audience: Patient, Pharmacy, Health Care Professional September 25, 2025 -- The U.S. Food and Drug Administration today removed the Risk Evaluation...